Deadline: Claim your Certificate of Attendance and CME/CE credits by Friday, November 13, 2026. The Evaluation Site closes after this date.
The prevalence of BReast Cancer Gene (BRCA1 or BRCA2) mutation ranges from roughly 1 in 300 to 1 in 800 individuals, and although the lifetime risk of breast cancer for the “typical American”
There are ample data to support the association between environmental exposures and health outcomes across the gynecologic, reproductive, and obstetric literature (1, 2). Much less is known about
A new biomarker predicts live birth after application of a test for embryo selection with an area under the receiver operating characteristic curve (AUC) of 0.72. The investigators conclude that
Advances in genomic medicine have substantially expanded the spectrum of genetic conditions associated with primary ovarian insufficiency (POI), enabling the identification of women and girls at
To study whether maternal PMOS is associated with altered ovarian activity in infant daughters during minipuberty.
To evaluate whether PGT-A laboratory was associated with diagnostic yield and live birth per single euploid embryo transfer.
Diagnostic evaluation for infertility in women should be conducted in a systematic, expeditious, and cost-effective manner to identify all the relevant factors with an initial emphasis on the
To investigate the contribution of variants in the GALNT gene family to male infertility and to evaluate the outcomes of intracytoplasmic sperm injection (ICSI) in infertile patients carrying
For much of the modern assisted reproductive technology (ART) era, efforts at clinical optimization have suffered from a strong embryo-centric bias. We grade, image, and biopsy the “seed” with
Displaying 1 to 10 of 1761 records